Vivanza Biosciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2022. For the fourth quarter, the company reported sales was INR 58.45 million compared to INR 29.06 million a year ago. Revenue was INR 81.4 million compared to INR 30.09 million a year ago. Net loss was INR 2 million compared to INR 1.28 million a year ago. Basic loss per share from continuing operations was INR 0.5 compared to INR 0.32 a year ago. Diluted loss per share from continuing operations was INR 0.5 compared to INR 0.32 a year ago.
For the full year, sales was INR 104 million compared to INR 98.88 million a year ago. Revenue was INR 112.29 million compared to INR 103.94 million a year ago. Net income was INR 3.33 million compared to INR 0.754 million a year ago. Basic earnings per share from continuing operations was INR 0.83 compared to INR 0.19 a year ago. Diluted earnings per share from continuing operations was INR 0.83 compared to INR 0.19 a year ago.